Results 181 to 190 of about 5,838,181 (363)
IRF4 is a prognostic biomarker in cervical cancer. IRF4 enhances radiosensitivity and inhibits tumor growth via PI3K/AKT/mTOR‐mediated autophagy. IRF4 boosts radiation response in vitro and in vivo. ABSTRACT Interferon regulatory factor 4 (IRF4), a critical member of the IRF transcription factor family, harbors an elusive biological role in cervical ...
Meihui Gao +9 more
wiley +1 more source
Navigating the evolving management of smoldering multiple myeloma. [PDF]
Hammami MB +6 more
europepmc +1 more source
Label-free protein-structure-sensitive live-cell microscopy for patient-specific assessment of myeloma therapy [PDF]
Francesca Gasparin +10 more
openalex +1 more source
A NEW CLASS OF HUMAN IMMUNOGLOBULINS. I. A UNIQUE MYELOMA PROTEIN.
D. Rowe, J. Fahey
semanticscholar +1 more source
Compound Library Screening Identified Cladribine as a Novel Radiosensitizer for Prostate Cancer
The combination of cladribine and irradiation significantly suppressed the growth of DU145‐derived tumors compared with the DMSO plus irradiation group in the mouse model. In addition, it also elevated the percentage of γH2AX‐positive cells after irradiation.
Toshiki Oka +26 more
wiley +1 more source
Headache as the initial symptom in two cases of multiple myeloma: a case report and literature review. [PDF]
Liu D, Du M, Gao X.
europepmc +1 more source
J. Haimovich, D. Givol, H. Eisen
semanticscholar +1 more source
The micropeptide altH19 interacts with phosphorylated CDK2 (p‐CDK2), subsequently activating CDK2 phosphorylation. This enhances the downstream E2F1 target gene RB activity, which accelerates DNA replication, ultimately leading to rapid myeloma cell mitosis and proliferation.
Yaxin Zhang +6 more
wiley +1 more source
Post-Transplant Double Malignancy: Multiple Myeloma and Papillary Renal Cell Carcinoma-A Case Report. [PDF]
Petrov A +4 more
europepmc +1 more source
Studies on the localization of radiolabeled antibodies to a mouse myeloma protein
A. Reif
semanticscholar +1 more source

